22/02/2024 09:15

Ansell Ltd (ANN) $24.26

ANN delivered a relatively benign report earlier this week, a big win compared to the past few years! While de-stocking dynamics continue to remain an issue, it has been interesting to see ANN recover this week after delivering revenue, EBIT and EPS all below consensus

Read more

25/01/2024 09:19

Ansell Ltd (ANN) $24.79

ANN was the best performer of the major healthcare names yesterday, and although the +2.8% rise wasn’t vaguely as dramatic as the crash by NAN, it was another example of an underperformer over recent years attracting some buying. The company downgraded mid-last year, compounding similar moves in 2022 and until they start delivering buying feels like “bottom picking” for the sake of it.

Read more

08/09/2023 09:10

Ansell Ltd (ANN) $22.28

When you’re cold you’re cold and that’s definitely been the case for both Ansell (ANN) and the Healthcare Sector in 2023 e.g. the Healthcare Index is -5.2% year-to-date compared to the Tech Sector which is up over 30%!

Read more

19/07/2023 09:17

Ansell Ltd (ANN) $23.88

ANN fell over -14% on Tuesday following a downgrade that took the stock to fresh  12-month lows, the downside momentum is looking likely to test/break its 2022 low which begs the question of where or if MM now have interest in ANN. The market has been aware of the company’s excess inventory issues for a while with customers no longer feeling the need to overstock protective products as COVID becomes a distant memory.

Read more

04/07/2023 09:41

Ansell Ltd (ANN) $27.14

ANN was the best-performing healthcare name yesterday gaining +1.5% although it remains well below its pre-COVID levels, not a good result for a health and safety business. Unpredictable supply/demand dynamics have weighed on ANN, and visibility of inventory in the onward value chain is still low which has left the market cautious toward further negative surprises, but with that comes potential value.

Read more

31/03/2023 09:13

Ansell Ltd (ANN) $26.83

ANN has more than halved from its mid-2021 high when in the middle of the pandemic people were stocking up on rubber gloves and hand sanitiser, but not much of either is in people’s shopping carts today.

Read more

29/11/2022 09:04

Ansell Ltd (ANN) $28.41

ANN has halved from its mid-2021 high when in the middle of the pandemic most people thought we would be wearing rubber gloves for the rest of our lives, however, the disappointing factor is the stock is now trading below its pre-Covid levels even as we have become a more sanitised and health conscious society. As we saw with HLS earlier this year we saw earnings downgrades as rising costs flowed down to decreasing margins, as we often say MM aren’t fans of companies who cannot rally on good news and that’s very much been the case with ANN over the last 2-years. • We feel the stock is reasonably priced trading on an Est. 15.5x earnings for 2022 but to entice MM we want to see some operational improvements dropping down to expansion in margins.

Read more

21/07/2022 09:01

Ansell Ltd (ANN) $25.70

ANN has fallen over 50% from its 2021 high back down towards its Covid lows, I’m sure most investors would have expected more from a business ideally positioned to benefit from the globe’s new health & safety environment as we deal with continually evolving new strains of the pandemic. Earlier this year we saw downgrades as rising costs have flowed down to decreasing margins. We aren’t...

Read more

03/06/2022 09:36

Ansell Ltd (ANN) $26.90

ANN has corrected 46% from its mid-2021 high and now finds itself down 38% for the financial year after disappointing the market with its post COVID performance, who would have thought the stock would be trading well under its 2020 highs in todays new health & safety world. Januarys major downgrade courtesy of rising costs and falling margins hasn’t been forgotten and for MM to be interested another leg lower is required for this health and industrial safety protection business.

Read more

22/02/2022 09:07

Ansell Ltd (ANN) $25.69

ANN has managed to hold around $25 following its significant downgrade in January on that awful combination of rising cost and falling margins. We would now want to see prices making fresh annual lows before the risk / reward would justify considering the out of favour healthcare and industrials supplies company.  

Read more